LevelJump Announces 2025 Third Quarter Results

LevelJump Healthcare Corp. (TSXV: JUMP) disclosed its financial performance for Q3 and the first nine months ended September 30, 2025. For the quarter, the company logged revenues of US $4.84 million, up 8.7 % from US $4.45 million in the same period of 2024. For the nine‑month span, revenues reached US $14.1 million, representing a 9.1 % increase over US $12.9 million a year earlier. Its wholly‑owned subsidiary, Canadian Teleradiology Services, Inc., delivered a Q3 EBITDA of US $836,000, and US $3.04 million for the nine‑month period. On a consolidated basis, LevelJump reported a Q3 net loss of US $(26,378) and EBITDA of US $600,677; for the nine months it posted net income of US $5,754 and EBITDA of US $1.90 million. Management noted that while a planned acquisition of two Calgary outpatient imaging clinics was terminated, the company remains focused on organic growth—expanding mammography, fluoroscopy and pain‑management services at its Alberta facilities. CEO Mitchell Geisler expressed satisfaction with the year‑over‑year momentum and reaffirmed the firm’s commitment to its urgent‑care and imaging‑services strategy. #LevelJump #Q3Results #HealthcareImaging #GrowthStrategy #SlimScan #GrowthStocks #CANSLIM